Notice Title

Consent to the Distribution of New Medicines

Publication Date
2 Oct 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go5500
Title
View PDF
File Type and Size
PDF (25 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Actilyse
Active Ingredient: Alteplase 10mg
Dosage Form: Powder for injection
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
   
Product: Actilyse
Active Ingredient: Alteplase 20mg
Dosage Form: Powder for injection
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
   
Product: Actilyse
Active Ingredient: Alteplase 50mg
Dosage Form: Powder for injection
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
   
Product: Bexsero
Active Ingredients: Neisseria meningitidis group B factor H binding protein fusion protein 50mcg
Neisseria meningitidis group B neisseria adhesin A protein 50mcg
Neisseria meningitidis group B neisseria heparin binding antigen fusion protein 50mcg
Neisseria meningitidis sergroup B outer membrane vesicles 25mcg
Dosage Form: Suspension for injection
New Zealand Sponsor: GlaxoSmithKline NZ Limited
Manufacturers: GlaxoSmithKline Vaccines SRL, Sovicille, Italy
Novartis Pharmaceutical Manufacturing GmbH, Kundl, Austria
   
Product: Fluad Quad
Active Ingredients: Influenza virus A (H1N1) haemagglutinin 15mcg
Influenza virus A (H3N2) haemagglutinin 15mcg
Influenza virus B (Victoria) haemagglutinin 15mcg
Influenza virus B (Yamagata) haemagglutinin 15mcg
Dosage Form: Suspension for injection
New Zealand Sponsor: Seqirus (NZ) Limited
Manufacturer: Seqirus Vaccines Limited, Liverpool, United Kingdom
   
Product: GONAL-f Pen for injection
Active Ingredient: Follitropin alfa 625IU/mL equivalent to 45.5mcg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Merck Serono SA, Aubonne, Switzerland
Merck Serono SpA, Bari, Italy
   
Product: Panadol Rapid Soluble
Active Ingredient: Paracetamol 500mg
Dosage Form: Soluble tablet
New Zealand Sponsor: Haleon New Zealand ULC
Manufacturers: Haleon Ireland Dungarvan Limited, Dungarvan, Ireland
Olic (Thailand) Limited, Ayutthaya, Thailand


Dated this 26th day of September 2025.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).